#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boomnews2026-01-12T20:55:09+00:00January 12th, 2026|Endpoints News|
FDA again rejects Atara, Pierre Fabre’s cell therapy for Epstein-Barr virusnews2026-01-12T13:59:22+00:00January 12th, 2026|Endpoints News|
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategynews2026-01-12T12:00:35+00:00January 12th, 2026|Endpoints News|
#JPM26: Day 1 at the JP Morgan Healthcare Conferencenews2026-01-12T12:00:14+00:00January 12th, 2026|Endpoints News|
Genentech CEO says pharmacy benefit manager shift will save $70Mnews2026-01-11T13:00:10+00:00January 11th, 2026|Endpoints News|
How Merck plans to set a buffer for Keytruda’s patent cliffnews2026-01-09T20:03:19+00:00January 9th, 2026|Endpoints News|
Orca adds $250M in financing to back launch of T cell therapynews2026-01-09T17:08:30+00:00January 9th, 2026|Endpoints News|
Novartis to build fourth US radiotherapy factory in Florida news2026-01-09T16:36:40+00:00January 9th, 2026|Endpoints News|
J&J strikes drug pricing, tariff deal with the White Housenews2026-01-09T14:17:44+00:00January 9th, 2026|Endpoints News|
Speculation builds about a deal for Revolution Medicinesnews2026-01-09T12:10:43+00:00January 9th, 2026|Endpoints News|
